Dicong Zhu

Title: Dicong Zhu: Innovator in Pancreatic Cell Research

Introduction

Dicong Zhu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the identification and selection of pancreatic internal secretion precursor cells. His innovative work has implications for diabetes research and regenerative medicine.

Latest Patents

Dicong Zhu holds a patent for the use of SUSD2 protein as a marker. This patent details how the SUSD2 protein can be utilized in the identification, selection, or separation of pancreatic internal secretion precursor cells and newborn pancreatic internal secretion cells. The analysis of gene expression in pancreatic endoderm cells, derived from induced differentiation of human pluripotent stem cells, reveals the enrichment of the SUSD2 gene in these specific cell types. The protein encoded by the SUSD2 gene acts as a receptor on cell membranes, facilitating the identification and separation of these crucial cells.

Career Highlights

Throughout his career, Dicong Zhu has worked with esteemed institutions such as Peking University and Beijing Ruipu Chenchuang Technology Co., Ltd. His research has garnered attention for its potential applications in understanding pancreatic functions and developing therapeutic strategies for related diseases.

Collaborations

Dicong Zhu has collaborated with notable researchers, including Hongkui Deng and Haisong Liu. These partnerships have furthered the exploration of pancreatic cell biology and the development of innovative solutions in the field.

Conclusion

Dicong Zhu's contributions to the field of pancreatic cell research highlight his role as an influential inventor. His work with the SUSD2 protein marks a significant advancement in biotechnology, paving the way for future innovations in medical science.